References
- Conally M., Kersting F., Dollery C. T. The clinical pharmacology of beta-adreno receptorblocking drug. Progr. cardiovasc. Dis. 1976; XIX: 203
- Drayer J. I. M., Kloppenborg P. W. C., Festen J., van't Laar A., Benraad T. J. Intrapatient comparison of treatment with chlorthalidone, spironolactone and propranolol in normoreninemic essential hypertension. Amer. J. Cardiol. 1975; 36: 716
- Falch D., Norman N. The cardiac response to a small i.v. dose of dihydralazine, a safe drug for diagnostic tests?, (In press.)
- Falch D. K., Norman N. Evaluation of a computerized technique for determination of cardiac output and central circulation times using gamma camera and 113m Indium. Scand. J. clin. Lab. Invest. 1974; 34: 207
- Frohlich E. D., Tarazi R. C., Dustan H. P., Page I. H. The paradox of beta-adrenergic blockade in hypertension. Circulation 1968; 37: 417
- Hansson L., Zweifier A. J., Stev J., Hunyor S. N. Hemodynamic effects of acute and prolonged β-adrenergic blockade in essential hypertension. Acta. med. scand. 1974; 196: 27
- Ibsen H., Sederberg-Olsen P. Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension. Clin Sci. 1973; 44: 129
- Lund-Johansen P. Hemodynamics in early essential hypertension. Acta med. scand. Suppl. 1967; 482: 1
- Lund-Johansen P. Hemodynamic changes at rest and during exercise in long-term beta blocker therapy for essential hypertension. Acta med. scand. 1974; 195: 117
- Lund-Larsen P. G., Sivertssen E. Haemodynamic effects of propranolol. Acta med sand. 1967; 186: 187
- Mookherjee S., Eirch R., Obeid A. J., Smulyan H. Hemodynamic and plasma renin effects of propranolol in essential hypertension. Archs intern Med. 1977; 137: 290
- Nayler W. G., McInnnes J., Swann J. B., Carson V., Lowe T. Effect of propranolol, a beta-adrenergic antagonist, on blood flow in the coronary and other vascular fields. Amer. Heart J. 1967; 73: 207
- Norman N. Effective plasma flow of the individual kidney. Determination on the basis of the [131I]-hippuran renogram. Scand. J. clin. Lab. Invest. 1972; 30
- Norman N., Sundsfjord J. A., Stiris G. Effective renal plasma flow (ERPF) of the individual kindey and renal venous renin activity (RENA) determined simultaneously before and after the administration of dihydralazine in renovascular hpertension. Scand. J. clin. Lab. Invest. 1975; 35: 219
- Sannerstedt R., Stenberg J., Vedin A., Wilhelmsson C., Werkø L. Chronic beta adrenergic blockade in arterial hypertension. Hemodynamic influence of dihydralazine and dynamic exercise and clinical effects of combined treatment. Amer. J. Cardiol. 1972; 29: 718
- Sannerstedt R., Stenberg J., Johnsson G., Werkø L. Hemodynamic interference of alprenolol with dihydralazine in normal and hypertensive man. Amer. J. Cardiol. 1971; 28: 316
- Hinebourne E., Fleming J., Hamer J. Effects of beta-adrenergic blockade during exercise in hypertensive and ischaemic heart-disease. Lancet 1967; ii: 1217
- Sullivan J. M., Adams D. F., Hollenberg N. K. β-adrenergic blockade in essential hypertension. Circulat. Res. 1976; 39: 532
- Sundsfjord J. A. Radiommunological determination of plasma renin activity during menstrual cycle and during acute progesterone administration. Acta Endocr. (Kbh.) 1971; 67: 174
- Sundsfjord J. A., Aakvaag A. Variations in plasma aldosterone and plasma renin activity througout the menstrual cycle, with special reference to the pre-ovulatory period. Acta Endocr. (Kbh.) 1973; 73: 499
- Werkø L., Varnauskas E., Ek J., Busht H., Thomasson B., Bergstrom J., Eliasch H. Studies on renal circulation and renal function in mitral valvular disease. II. Effect of Aprezolin. Circulation 1954; 9: 700
- Wilkinson E. L., Backman H., Hecht H. H. Cardiovascular and renal adjustments to a hypotensive agent. J. clin. Invest. 1952; 31: 872